Reemergence of PML in Natalizumab-Treated Patients - New Cases, Same Concerns

被引：68
作者：
Major, Eugene O. [1 ]
机构：
[1] NINDS, Lab Mol Med & Neurosci, Bethesda, MD 20892 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 11期
关键词：
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; ANTIBODY NATALIZUMAB; CELLS;
D O I：
10.1056/NEJMp0906248
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1041 / 1043
页数：3
相关论文
共 5 条
[1]   Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab [J].
Bonig, Halvard ;
Wundes, Annette ;
Chang, Kai-Hsin ;
Lucas, Sylvia ;
Papayannopoulou, Thalia .
BLOOD, 2008, 111 (07) :3439-3441
[2]   Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project [J].
Carson, Kenneth R. ;
Evens, Andrew M. ;
Richey, Elizabeth A. ;
Habermann, Thomas M. ;
Focosi, Daniele ;
Seymour, John F. ;
Laubach, Jacob ;
Bawn, Susie D. ;
Gordon, Leo I. ;
Winter, Jane N. ;
Furman, Richard R. ;
Vose, Julie M. ;
Zelenetz, Andrew D. ;
Mamtani, Ronac ;
Raisch, Dennis W. ;
Dorshimer, Gary W. ;
Rosen, Steven T. ;
Muro, Kenji ;
Gottardi-Littell, Numa R. ;
Talley, Robert L. ;
Sartor, Oliver ;
Green, David ;
Major, Eugene O. ;
Bennett, Charles L. .
BLOOD, 2009, 113 (20) :4834-4840
[3]   Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients [J].
Lindberg, Raija L. P. ;
Achtnichts, Lutz ;
Hoffmann, Francine ;
Kuhle, Jens ;
Kappos, Ludwig .
JOURNAL OF NEUROIMMUNOLOGY, 2008, 194 (1-2) :153-164
[4]   Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy [J].
Yousry, TA ;
Major, EO ;
Ryschkewitsch, C ;
Fahle, G ;
Fischer, S ;
Hou, J ;
Curfman, B ;
Miszkiel, K ;
Mueller-Lenke, N ;
Sanchez, E ;
Barkhof, F ;
Radue, EW ;
Jager, HR ;
Clifford, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) :924-933
[5]   The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans [J].
Zohren, Fabian ;
Toutzaris, Diamandis ;
Klaerner, Viola ;
Hartung, Hans-Peter ;
Kieseier, Bernd ;
Haas, Rainer .
BLOOD, 2008, 111 (07) :3893-3895
1